Evotec SE (EVO) Discusses Horizon Initiative as Next Phase in Strategic Transformation for Operational Excellence and Growth Transcript
Source: SeekingAlpha
2026-03-10 18:30:20 ET
Evotec SE (EVO) Discusses Horizon Initiative as Next Phase in Strategic Transformation for Operational Excellence and Growth March 10, 2026 10:00 AM EDT...
Read the full article on Seeking Alpha
For further details see:
Evotec SE (EVO) Discusses Horizon Initiative as Next Phase in Strategic Transformation for Operational Excellence and Growth Transcript
Evotec SE
NASDAQ: EVO
EVO Trading
-2.4% G/L:
$2.435 Last:
93,688 Volume:
$2.53 Open:
EVO Latest News
January 08, 2026 01:50:00 am
Just - Evotec Biologics Receives Grant for AI-Driven Optimization of Monoclonal Antibody Developability for Affordable Access
January 02, 2026 12:30:00 am
Evotec Appoints Dr. Sarah Fakih as EVP, Head of Global Communications and Investor Relations
December 08, 2025 01:20:00 am
Evotec Closes Sale of Just - Evotec Biologics' Toulouse Site to Sandoz
December 04, 2025 02:50:00 am
Evotec-Partner Bayer Starts Phase 2 Study for Treatment of Patients with Alport Syndrome
EVO Stock Data
$320,181,806
73,171,742
N/A
9
N/A
Biotechnology & Life Sciences
Healthcare
DE
Hamburg
